Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

271.21
Delayed Data
As of Apr 28
 -5.36 / -1.94%
Today’s Change
205.42
Today|||52-Week Range
307.33
+3.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues5.9B8.6B9.3B10.2B
 
 
 
 
 
Cost of Goods Sold668.9M972.6M1.0B1.1B
 
 
 
 
 
Depreciation And Amortization531.7M637.3M600.4M682.7M
 
 
 
 
 
 
Operating ExpensesGross Income4.7B7.0B7.7B8.4B
 
 
 
 
 
General Expenses3.2B4.1B4.1B3.9B
 
 
 
 
 
Research And Development1.4B1.9B2.0B2.0B
 
 
 
 
 
Total Operating Expenses4.4B5.7B5.7B5.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.4B2.8B3.6B4.5B
 
 
 
 
 
Extraordinary Credit9.9M38.9M0.00--
 
 
 
Extraordinary Charge-2.8M-67.9M-142.8M-586.6M
 
 
 
 
 
Pre-Tax Equity Earnings1.1B1.1B1.3B1.2B
 
 
 
 
 
Interest Expense On Debt39.7M35.9M105.9M260.0M
 
 
 
 
 
Equity In Earnings-17.2M-15.1M-12.5M0.00
 
 
 
 
Other Expenses-6.1M32.1M141.8M10.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income2.5B3.9B4.8B4.9B
 
 
 
 
 
Income Taxes-601.0M-989.9M-1.2B-1.2B
 
 
 
 
 
Minority Interest0.00-6.8M-46.2M-7.1M
 
 
 
 
Net Income1.9B2.9B3.5B3.7B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS236.9M236.4M230.7M218.4M
 
 
 
 
 
Shares To Calculate EPS Diluted238.3M237.2M231.2M218.8M
 
 
 
 
 
 
Earnings Per ShareEPS$7.81$12.37$15.34$16.93
 
 
 
 
 
EPS Diluted$7.81$12.37$15.34$16.92